Dexbrompheniramine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine | |
| Clinical data | |
| Trade names | Drixoral |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a606008 |
| Pregnancy cat. | ? |
| Legal status | OTC (US) OTC(Canada) |
| Pharmacokinetic data | |
| Half-life | 25 hours |
| Identifiers | |
| CAS number | 132-21-8 |
| ATC code | R06AB06 |
| PubChem | CID 16960 |
| DrugBank | APRD00770 |
| ChemSpider | 16068 |
| UNII | 75T64B71RP |
| ChEBI | CHEBI:59269 |
| ChEMBL | CHEMBL1201287 |
| Chemical data | |
| Formula | C16H19BrN2 |
| Mol. mass | 319.24 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Dexbrompheniramine (Drixoral) is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria. It is the pharmacologically active dextrorotatory isomer of brompheniramine. It is marketed under the name Drixoral in the US and Canada, which is a combination of dexbrompheniramine and pseudoephedrine.
[edit] See also
[edit] References
|
||||||||||||||||||||||||||||||||||||||||||||||